- •Timing of VTEp has no effect on mortality or delayed craniectomy in patients with acute subdural hematomas.
- •Early VTEp (≤48 h) is associated with less thromboembolism complications compared to late VTEp (>48 h).
- •LMWH is independently associated with a lower mortality compared to UH.
The purpose of this study was to evaluate the optimal timing and type of pharmacological venous thromboembolism prophylaxis (VTEp) in patients with severe blunt head trauma with acute subdural hematomas (ASDH).
Matched cohort study using ACS-TQIP database (2013–2016) including patients with isolated ASDH. Outcomes of matched patients receiving early prophylaxis (EP, ≤48 h) and late prophylaxis (LP, >48 h) were compared with univariable and multivariable regression analysis.
In 1,660 matched cases VTE complications (3.1% vs 0.5%, p < 0.001) were more common in the LP compared to the EP group. Multivariable regression analysis identified EP as an independent protective factor for VTE complications (OR 0.169, p < 0.001) but not mortality (p = 0.260). The adjusted risk for delayed craniectomy was not associated with EP compared to LP (p = 0.095). LMWH was independently associated with a lower mortality (OR 0.480, p = 0.008) compared to UH.
Early VTEp (≤48 h) does not increase the risk for craniectomies and is independently associated with fewer VTE complications in patients with isolated ASDH. LMWH was independently associated with a lower mortality compared to UH.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to The American Journal of Surgery
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Surveillance for traumatic brain injury-related deaths--United States, 1997-2007.MMWR Surveill Summ. 2011 May 6; 60 (PubMed PMID: 21544045. Epub 2011/05/06): 1-32
- Incidence of venous thromboembolism in patients with traumatic brain injury.Am J Surg. 2007 Mar; 193 (discussion 3-4. PubMed PMID: 17320539. Epub 2007/02/27): 380-383
- Isolated traumatic brain injury and venous thromboembolism.J Trauma Acute Care Surg. 2014 Aug; 77 (PubMed PMID: 25058248. Epub 2014/07/25): 238-242
- Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis.Am J Pathol. 1989 May; 134 (PubMed PMID: 2719077. Pubmed Central PMCID: PMC1879887. Epub 1989/05/01): 1087-1097
- Sources of tissue factor.Semin Thromb Hemost. 2006 Feb; 32 (PubMed PMID: 16479458. Epub 2006/02/16): 11-23
- A prospective study of venous thromboembolism after major trauma.N Engl J Med. 1994 Dec 15; 331 (PubMed PMID: 7969340. Epub 1994/12/15): 1601-1606
- Traumatic brain injury is associated with the development of deep vein thrombosis independent of pharmacological prophylaxis.J Trauma. 2009 May; 66 (PubMed PMID: 19430251. Epub 2009/05/12): 1436-1440
- Thromboprophylaxis for trauma patients.Cochrane Database Syst Rev. 2013 Mar 28; (PubMed PMID: 23543562. Epub 2013/04/02): CD008303
- Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery.N Engl J Med. 1998 Jul 9; 339 (PubMed PMID: 9654538. Epub 1998/07/09): 80-85
- Pharmacological thromboembolic prophylaxis in traumatic brain injuries: low molecular weight heparin is superior to unfractionated heparin.Ann Surg. 2017 Sep; 266 (PubMed PMID: 28650361. Epub 2017/06/27): 463-469
- Is low-molecular-weight heparin safe for venous thromboembolism prophylaxis in patients with traumatic brain injury? A Western Trauma Association multicenter study.J Trauma Acute Care Surg. 2012 Sep; 73 (PubMed PMID: 22929493. Epub 2012/08/30): 625-628
- ACS TQIP Best Practices in the Management of Traumatic Brain Injury.Jan 2015: 17-18
- Anticoagulant chemoprophylaxis in patients with traumatic brain injuries: a systematic review.J Trauma Acute Care Surg. 2020 Mar; 88 (PubMed PMID: 31923051. Epub 2020/01/11): 454-460
- Prospective evaluation of the safety of enoxaparin prophylaxis for venous thromboembolism in patients with intracranial hemorrhagic injuries.Arch Surg. 2002 Jun; 137 (discussion -2. PubMed PMID: 12049541. Epub 2002/06/07): 696-701
- A national survey of thromboprophylaxis in traumatic brain injury in the United Kingdom.Br J Neurosurg. 2016; 30 (PubMed PMID: 26999404. Epub 2016/03/22): 240-245
- Chemoprophylaxis and venous thromboembolism in traumatic brain injury at different trauma centers.Am Surg. 2020 Apr 1; 86 (PubMed PMID: 32391761. Epub 2020/05/12): 362-368
- Timing of venous thromboembolism chemoprophylaxis after traumatic brain injury.J Crit Care. 2018 Feb; 43 (PubMed PMID: 28850931. Epub 2017/08/30): 75-80
- Timing of pharmacologic venous thromboembolism prophylaxis in severe traumatic brain injury: a propensity-matched cohort study.J Am Coll Surg. 2016 Oct; 223 (e5. PubMed PMID: 27453296. Epub 2016/07/28): 621-631
- Safety and efficacy of early thromboembolism chemoprophylaxis after intracranial hemorrhage from traumatic brain injury.J Neurosurg. 2013 Dec; 119 (PubMed PMID: 24053504. Epub 2013/09/24): 1576-1582
- Chemical venous thromboembolic prophylaxis is safe and effective for patients with traumatic brain injury when started 24 hours after the absence of hemorrhage progression on head CT.J Trauma Acute Care Surg. 2012 Aug; 73 (PubMed PMID: 22846950. Epub 2012/08/01): 426-430
- A randomized, double-blinded, placebo-controlled pilot trial of anticoagulation in low-risk traumatic brain injury: the Delayed versus Early Enoxaparin Prophylaxis I (DEEP I) study.J Trauma Acute Care Surg. 2012 Dec; 73 (PubMed PMID: 22914079. Epub 2012/08/24): 1434-1441
- Chemoprophylaxis for venous thromboembolism in traumatic brain injury: a review and evidence-based protocol.Clin Neurol Neurosurg. 2014 Aug; 123 (PubMed PMID: 25012022. Epub 2014/07/12): 109-116
- The effectiveness and safety of pharmacological prophylaxis against venous thromboembolism in patients with moderate to severe traumatic brain injury: a systematic review and meta-analysis.J Trauma Acute Care Surg. 2016 Sep; 81 (PubMed PMID: 27244574. Epub 2016/06/01): 567-574
- Timing of venous thromboprophylaxis in isolated severe pelvic fracture: effect on mortality and outcomes.Injury. 2019 Mar; 50 (PubMed PMID: 30797543. Epub 2019/02/25): 697-702
- Timing and type of venous thromboembolic prophylaxis in isolated severe liver injury managed Non-operatively.World J Surg. 2021 Mar; 45 (PubMed PMID: 33211165. Epub 2020/11/20): 746-753
- Neuroprotective effects of ultra-low-molecular-weight heparin on cerebral ischemia/reperfusion injury in rats: involvement of apoptosis, inflammatory reaction and energy metabolism.Int J Mol Sci. 2013 Jan 17; 14 (PubMed PMID: 23344063. Pubmed Central PMCID: PMC3565356. Epub 2013/01/25): 1932-1939
- Does enoxaparin interfere with HMGB1 signaling after TBI? A potential mechanism for reduced cerebral edema and neurologic recovery.J Trauma Acute Care Surg. 2016 Mar; 80 (discussion 7-9. PubMed PMID: 26670109. Pubmed Central PMCID: PMC5345267. Epub 2015/12/17): 381-387
- Enoxaparin ameliorates post-traumatic brain injury edema and neurologic recovery, reducing cerebral leukocyte endothelial interactions and vessel permeability in vivo.J Trauma Acute Care Surg. 2015 Jul; 79 (PubMed PMID: 26091318. Pubmed Central PMCID: PMC5448137. Epub 2015/06/20): 78-84
- Enoxaparin reduces brain edema, cerebral lesions, and improves motor and cognitive impairments induced by a traumatic brain injury in rats.J Neurotrauma. 2000 Nov; 17 (PubMed PMID: 11101208. Epub 2000/12/02): 1055-1065
- Neuroprotective profile of enoxaparin, a low molecular weight heparin, in in vivo models of cerebral ischemia or traumatic brain injury in rats: a review.CNS Drug Rev. 2002 Spring; 8 (PubMed PMID: 12070524. Pubmed Central PMCID: PMC6741656. Epub 2002/06/19): 1-30
- Low-molecular-weight heparin reduces hyperoxia-augmented ventilator-induced lung injury via serine/threonine kinase-protein kinase B.Respir Res. 2011 Jul 5; 12 (PubMed PMID: 21726460. Pubmed Central PMCID: PMC3136419. Epub 2011/07/06): 90
- Effectiveness of low-molecular-weight heparin versus unfractionated heparin to prevent pulmonary embolism following major trauma: a propensity-matched analysis.J Trauma Acute Care Surg. 2017 Feb; 82 (PubMed PMID: 27906870. Epub 2016/12/03): 252-262
- A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma.N Engl J Med. 1996 Sep 5; 335 (PubMed PMID: 8703169. Epub 1996/09/05): 701-707
- Guidelines for the management of severe traumatic brain injury.Neurosurgery. 2017 Jan 1; 80 (PubMed PMID: 27654000. Epub 2016/09/23): 6-15
Published online: August 02, 2021
Accepted: July 27, 2021
Received in revised form: July 26, 2021
Received: March 31, 2021
© 2021 Elsevier Inc. All rights reserved.